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aa amino acid 
Ala L-alanine 
APC antigen presenting cell 
Asp L-aspartic acid 
Asn L-asparagine 
BAIB iodobenzene diacetate 
BHA benzhydrylamine 
Boc t-butyloxycarbonyl 
BSA bovine serum albumin 
Cbz benzyloxycarbonyl 
CD celiac disease 
CDI 1,1’-carbonyl diimidazole 
Chg cyclohexyl-L-glycine 
Cha cyclohexyl-L-alanine 
Cq quaternary carbon 
Cys L-cysteine 
d doublet 
D L-aspartic acid 
DCM dichloromethane 
dd doublet of doublets 
ddd doublet of doublet of doublets  





DMSO dimethyl sulfoxide 
DON 6-diazo-5-oxo-norleucine  
Dpr L-2,3-diaminopropionic acid 
dt double triplet 










EDTA ethylenediaminetetraacetic acid 
eq equivalents 
ESI electrospray ionization 







GFD gluten-free diet 
Gln L-glutamine 
Glu L-glutamic acid 
Gly glycine 
GS gramicidin S (Soviet) 














HPLC high performance liquid 
chromatography 




IC50 concentration at which 50% 
















IR infrared spectroscopy 










MAA morpholine amino acid 




MHC major histocompatibility 
complex 
MIC minimal inhibitory  
concentration 




MRSA methillicin resistant 
Staphylococcus Aureus 
MS mass spectrometry 
M micromolar 
m/z  mass over charge ratio 
NMR nuclear magnetic resonance 
nM nanomolar 
NMM N-methylmorpholine  
NMP N-methyl-2-pyrrolidone  
NOE nuclear Overhauser effect 
Orn L-ornithine 
P L-proline 
PBS phosphate buffered saline  





















PPII polyproline type II 








RCM ring-closing metathesis 
RP reversed phase 
S  L-serine 
s singlet  
SAA sugar amino acid  
Ser L-serine 
SPPS solid phase peptide synthesis 
t triplet 
TBAF tetrabutylammonium fluoride 
tBu tert-butyl 
TCR T cell receptor 
td triple doublet 
TEMPO 2,2,6,6-
tetramethylpiperidinooxy 
TFA trifluoroacetic acid 
TG2  tissue transglutaminase 
THF tetrahydrofuran 
TIS triisopropylsilane 





tTG tissue transglutaminase 
UV ultraviolet 
V L-valine 
Val L-valine 
W L-tryptophan 
Y L-tyrosine 
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